ACLARIS THERAPEUTICS, INC.

Profile

Company Names

ACLARIS THERAPEUTICS, INC.

Addresses

701 LEE ROAD, SUITE 103, WAYNE, PA 19087

640 LEE ROAD, SUITE 200, WAYNE, PA 19087

640 LEE ROAD, SUITE 200, WAYNE, PA 19087

101 LINDENWOOD DRIVE, SUITE 400, MALVERN, PA 19355

SUITE 400, 101 LINDENWOOD DRIVE, MALVERN, PA 19355

Phone Numbers

484-324-7933
484-321-5554

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2012

State Incorporated:

DELAWARE

Total Amount Raised:

$192,534,260.00

Number of Funding Rounds:

7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2024-11-19 
$79,999,999.00 
$79,999,999.00 
$0.00 
Equity 
6
2020-03-30 
$11,000,000.00 
$11,440,000.00 
$440,000.00 
Debt 
5
2017-08-03 
$10,000,000.00 
$12,500,000.00 
$2,500,000.00 
Equity 
4
2016-06-02 
$20,000,017.00 
$20,000,017.00 
$0.00 
Equity 
3
2015-08-28 
$40,000,000.00 
$40,000,000.00 
$0.00 
Equity 
2
2014-09-30 
$10,644,244.00 
$21,288,488.00 
$10,644,244.00 
Equity 
1
2012-08-30 
$20,890,000.00 
$20,890,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
KAMIL 
 
ALI-JACKSON 
EXECUTIVE OFFICER
YAUPON THERAPEUTICS INC   |  CEPTARIS THERAPEUTICS, INC   |  ALEXAR THERAPEUTICS, INC.   |  ACLARIS THERAPEUTICS, INC.
KEVIN 
 
BALTHASER 
EXECUTIVE OFFICER
ACLARIS THERAPEUTICS, INC.
RICHARD 
A. 
BIERLY 
DIRECTOR
ACLARIS THERAPEUTICS, INC.
ALBERT 
 
CHA 
DIRECTOR
NEOMEND INC   |  VICEPT THERAPEUTICS, INC.   |  TRIA BEAUTY, INC.   |  HEALTH360, INC.   |  YAUPON THERAPEUTICS INC   |  MEDLEY HEALTH, INC.   |  AIRXPANDERS INC   |  VIVO VENTURES VII AFFILIATES FUND, L.P.   |  CEPTARIS THERAPEUTICS, INC   |  ACLARIS THERAPEUTICS, INC.   |  CARBYLAN BIOSURGERY, INC   |  PRONAI THERAPEUTICS INC   |  MINERVA SURGICAL INC   |  CARBYLAN THERAPEUTICS, INC.   |  ASCENDIS PHARMA A/S   |  VIVO CAPITAL FUND VIII, L.P.   |  VIVO CAPITAL SURPLUS FUND VIII, L.P.   |  MENLO THERAPEUTICS, INC.   |  VIVO OPPORTUNITY FUND, L.P.   |  VIVO CAPITAL FUND IX, L.P.   |  VIVO OPPORTUNITY CO-INVEST, L.P.   |  VIVO OPPORTUNITY CO-INVEST (W), L.P.
HUGH 
 
DAVIS 
EXECUTIVE OFFICER, DIRECTOR
ACLARIS THERAPEUTICS, INC.   |  ACKWEST GROUP, INC.
BRETT 
 
FAIR 
EXECUTIVE OFFICER
ACLARIS THERAPEUTICS, INC.
DAVID 
 
GORDON 
EXECUTIVE OFFICER
TEN NETWORK HOLDINGS LTD   |  SMART PACKAGING, LLC   |  RICHER POUR, INC.   |  GORDON ASSOCIATES LP   |  PHARMACIELO LTD.   |  PHARMACIELO HOLDINGS LTD.   |  EMERALD COAST ESTATES, LLC   |  ALUMIER GROUP HOLDINGS LTD   |  ACLARIS THERAPEUTICS, INC.   |  GT SPIRITS, INC.   |  BLUON, INC.   |  GORDON AD VENTURE FUND LLC
MAXINE 
 
GOWEN 
DIRECTOR
TREVENA INC   |  TAMUROBIO INC.   |  ACLARIS THERAPEUTICS, INC.   |  PANORAMA MEDICINE, INC.
WILLIAM 
 
HUMPHRIES 
DIRECTOR
CLEARSIDE BIOMEDICAL, INC.   |  ACLARIS THERAPEUTICS, INC.   |  BRYN PHARMA, LLC
JAMES 
 
LOEROP 
EXECUTIVE OFFICER
ACLARIS THERAPEUTICS, INC.
ANAND 
 
MEHRA 
DIRECTOR
MARINUS PHARMACEUTICALS INC   |  VICEPT THERAPEUTICS, INC.   |  AERIE PHARMACEUTICALS INC   |  NEXTWAVE PHARMACEUTICALS INC   |  SPARK THERAPEUTICS, INC.   |  ACLARIS THERAPEUTICS, INC.   |  FIRST AID BEVERAGES, INC.   |  SOFINNOVA VENTURE PARTNERS X, L.P.   |  MERUS N.V.   |  AMPLYX PHARMACEUTICALS, INC.
VINCENT 
 
MILANO 
DIRECTOR
ACLARIS THERAPEUTICS, INC.
CHRISTOPHER 
 
MOLINEAUX 
DIRECTOR
ACLARIS THERAPEUTICS, INC.   |  NEXEOS DIAGNOSTICS, INC.
JOSEPH 
 
MONAHAN 
EXECUTIVE OFFICER
CONFLUENCE LIFE SCIENCES, INC.   |  CONESTOGA MICRO CAP FUND, LP   |  GEAR UP SPORTS, INC.   |  ACLARIS THERAPEUTICS, INC.
KETAN 
 
PATEL 
DIRECTOR
INTELLEFLEX CORP   |  SHOPWELL SOLUTIONS, INC.   |  ACLARIS THERAPEUTICS, INC.   |  RAINMAKER HOLDINGS II, LLC   |  IVENIX, INC.   |  GENOA PHARMACEUTICALS, INC.   |  NFLECTION THERAPEUTICS, INC.   |  MENLO THERAPEUTICS, INC.   |  AMPHORA MEDICAL, INC.   |  FOREST CITY REALTY TRUST, INC.   |  AZAD ALLIANCE 2019 LLC   |  AVALYN PHARMA INC.   |  RALLYBIO HOLDINGS, LLC   |  REDIRECT HEALTH, LLC   |  FOREST CITY ENTERPRISES, L.P.   |  AVIVOMED INC.   |  ABK BIOMEDICAL INC   |  FC 1275 NJ MEMBER LLC   |  FC TOD MF II HOLDINGS LLC   |  FC TOD BTR HOLDINGS I LLC   |  COMANCHE BIOPHARMA CORP.   |  LOS ANGELES BIOSCIENCES, INC.   |  RAINMAKER CAPITAL LLC
CHRISTOPHER 
 
POWALA 
EXECUTIVE OFFICER
VICEPT THERAPEUTICS, INC.   |  ACLARIS THERAPEUTICS, INC.   |  NFLECTION THERAPEUTICS, INC.
ANDREW 
 
POWELL 
DIRECTOR
NEOS SPECIAL OPPORTUNITIES FUND LP   |  NEOS SPECIAL OPPORTUNITIES CASH HOLDING LP   |  ACLARIS THERAPEUTICS, INC.   |  LANDEC CORP \CA\   |  HENDERSON DISTILLING COMPANY, LLC
BRYAN 
 
REASONS 
DIRECTOR
ACLARIS THERAPEUTICS, INC.
FRANK 
 
RUFFO 
EXECUTIVE OFFICER
ACLARIS THERAPEUTICS, INC.
ANDREW 
 
SCHIFF 
DIRECTOR
SIRION HOLDINGS, INC.   |  SIRION HOLDINGS, INC.   |  TRANSENTERIX INC   |  PLANET BIOPHARMACEUTICALS, INC.   |  MIRAMAR LABS INC   |  ARMGO PHARMA INC   |  UPTAKE MEDICAL CORP   |  AGILE THERAPEUTICS INC   |  ACLARIS THERAPEUTICS, INC.
STUART 
 
SHANLER 
EXECUTIVE OFFICER
ACLARIS THERAPEUTICS, INC.
STUART 
D. 
SHANLER 
EXECUTIVE OFFICER
ACLARIS THERAPEUTICS, INC.
STEPHEN 
 
TULLMAN 
DIRECTOR
VICEPT THERAPEUTICS, INC.   |  YAUPON THERAPEUTICS INC   |  CEPTARIS THERAPEUTICS, INC   |  ACLARIS THERAPEUTICS, INC.   |  ALEXAR THERAPEUTICS, INC.   |  ZOOMI, INC.   |  VELICEPT THERAPEUTICS, INC.   |  RALEXAR THERAPEUTICS, INC.   |  ONSPIRA THERAPEUTICS, INC.   |  NEXEOS DIAGNOSTICS, INC.
STEPHEN 
A. 
TULLMAN 
DIRECTOR
ACLARIS THERAPEUTICS, INC.   |  MYOTA, INC.
STEVEN 
A. 
TULLMAN 
DIRECTOR
ACLARIS THERAPEUTICS, INC.
NEAL 
 
WALKER 
EXECUTIVE OFFICER, DIRECTOR
VICEPT THERAPEUTICS, INC.   |  ACLARIS THERAPEUTICS, INC.   |  SEBACIA, INC.   |  ALEXAR THERAPEUTICS, INC.   |  ACTIVE PROTECTIVE TECHNOLOGIES, INC.   |  ALDEYRA THERAPEUTICS, INC.   |  ZOOMI, INC.   |  RALEXAR THERAPEUTICS, INC.   |  MYOTA, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-12-04
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2024-11-19 
2020-04-08
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2020-03-30 
2018-08-13
D/A
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-08-03 
2017-08-14
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-08-03 
2016-06-14
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2016-06-02 
2015-09-11
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-08-28 
2014-10-08
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-09-30 
2012-09-10
D
Link
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2012-08-30 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
LEERINK PARTNERS LLC
39011
NONE
NONE
CANTOR FITZGERALD + CO.
134
NONE
NONE
WILLIAM BLAIR + COMPANY L.L.C.
1252
NONE
NONE
GUGGENHEIM SECURITIES, LLC
40638